Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Amundi›WEL9

WEL9

Amundi S&P World Health Care Screened UCITS ETF

Acc

EUR

Passive ETF Equity ESG

Not rated

The WEL9 Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: S&P World Health Care Weighted & Screened Index. The WEL9 ETF provides physical exposure, so by buying it you actually own parts of all the 83 underlying holdings. The dividend policy is capitalization.

€11.68

N/A

Data as of 07/23/26

1D price range

N/A

52W price range

€9.63€11.90

YTD Perf.

+3.27%

YTD Flows

Annualized volatility

Fund AuM

€863M

Share class AuM

€737M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

IE0006FM6MI8

TER

0.18%

Inception date

9/20/2022

Issuer

Amundi

Benchmark

S&P World Health Care Weighted & Screened Index

Replication method

Dividend policy

Capitalization

Compare similar ETFs

ETF Name	1w perf.
WELZ Amundi S&P World Health Care Screened UCITS ETF	+0.02%
WDHE Invesco S&P World Health Care ESG UCITS ETF	+0.72%
IXJ iShares Global Healthcare ETF	+0.58%
IXJ iShares Global Healthcare ETF (AU)	+0.08%
XHC iShares Global Healthcare Index ETF	+0.90%
WHEA State Street SPDR MSCI World Health Care UCITS ETF	+0.53%
XDWH Xtrackers MSCI World Health Care UCITS ETF	-0.32%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	+0.71%
DRUG BetaShares Global Healthcare ETF - Currency Hedged	+0.57%
CBUF iShares MSCI World Health Care Sector Advanced UCITS ETF	+0.41%
ZGHC BMO Global Health Care Fund Active ETF Series	+1.79%
JDOC JPMorgan Healthcare Leaders ETF	+0.61%
XDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF	-1.05%
TDOC TD Global Healthcare Leaders Index ETF	-1.06%
HRTS Tema GLP-1, Obesity & Cardiometabolic ETF	+0.31%

API

PerformanceDec 31, 2025 - Jul 23, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

98.26%

Consumer Non-Cyclicals

1.41%

Other

0.33%

Latest WEL9 news

No content available for this fund

FAQ about WEL9

WEL9 is a Passive ETF. This ETF provides exposure to Other Large and Mid-Cap Developed markets Health Care Equities.

WEL9 tracks the S&P World Health Care Weighted & Screened Index - USD, through a full replication replication method.

WEL9 carries a total expense ratio (TER) of 0.18%, indicating the annual cost for holding the fund.

WEL9 was introduced to the market on September 20, 2022. It trades on Sweden, among other exchanges

Amundi S&P World Health Care Screened UCITS ETF, WEL9, is provided by Amundi. Learn more about Amundi here.

Yes, WEL9 is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

WEL9 oversees €737M in assets as of July 23, 2026.

WEL9 follows a capitalizing, meaning it reinvests income within the fund.

As of June 30, 2026, WEL9 has significant geographic allocations in USA, Switzerland and United Kingdom.

As of June 30, 2026, WEL9 focuses largely on Healthcare and Consumer Non-Cyclicals.

As of June 30, 2026, WEL9 holds 83 positions in its portfolio, with 65.39% of assets concentrated in its top 15 holdings.

As of June 30, 2026, WEL9 top three holdings include Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..

The base currency of WEL9 is EUR.

Top 10 holdings

Data as of 06/30/26

Eli Lilly & Co.

12.07%

AbbVie, Inc.

8.08%

UnitedHealth Group, Inc.

5.25%

Novartis AG

5.15%

AstraZeneca PLC

5.10%

Merck & Co., Inc.

4.89%

Roche Holding AG

3.90%

Amgen, Inc.

3.53%

Gilead Sciences, Inc.

3.16%

Intuitive Surgical, Inc.

2.86%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Amundi S&P World Health Care Screened UCITS ETF

FAQ about WEL9

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US